Author: CSN
The single biggest cannabis catalyst in years is rapidly approaching: 2 marijuana stocks to buy now
Two of the top multi-state operators have seen their shares jump since reclassifying news came out, but they may no…
Why Banks Are Finally Warming Up To Cannabis Banking
For more than a decade, the American cannabis industry has occupied a strange legal purgatory: legal in some form in…
Austin medical marijuana company sues hemp sellers over alleged sky-high THC levels
Austin-based Texas Original accuses hemp companies of selling illegal marijuana products and misleading consumers …
Trulieve Makes History With First NYSE Cannabis Listing
Trulieve’s upcoming NYSE listing follows the Trump administration’s decision to reclassify medical marijuana under federal law.
TLRY stock back into the limelight – a look at the key developments that sparked investor optimism
The DEA rescheduling hearing that could reclassify marijuana is expected to be held on June 29. ・On Thursday, the Trump…
The Great Cannabis Shift: Navigating the Federal Rescheduling of Medical Marijuana
Announced April 22, 2026, and effective April 28, 2026, the Justice Department (Attorney General) and the Drug Enforcement Administration (DEA)…
Trulieve Cannabis to Debut on NYSE After Restructuring, U.S. Marijuana Reclassification
Trulieve Cannabis received regulatory approval to list its shares on the New York Stock Exchange, becoming the first cannabis company…
Dramatic shifts in Oklahoma’s cannabis industry leaves growers struggling
A 2023 study prepared for the Oklahoma Medical Marijuana Authority found that the state’s regulated cannabis supply exceeded patient demand…
Fresno man calls Paso Robles cannabis business owner the N-word in dispute. See video
The man, who was trying to buy cannabis from Dubs Green Garden, accused owner Ernest Hall of battery, while the…
Cannabis Stocks Are Climbing — And the Biggest Catalyst Hasn’t Even Arrived Yet
Cannabis stocks remain in focus as a key federal hearing approaches, with Green Thumb Industries and Curaleaf among closely watched…
Recent Comments